Oral Nipah Vaccine
- Funded by UK Research and Innovation (UKRI)
- Total publications:0 publications
Grant number: 10027019
Grant search
Key facts
Disease
Infection caused by Nipah virusStart & end year
20222023Known Financial Commitments (USD)
$378,076.48Funder
UK Research and Innovation (UKRI)Principal Investigator
Andrew BACONResearch Location
United Kingdom, United KingdomLead Research Institution
IOSBIO LTD, Innovate UKResearch Priority Alignment
N/A
Research Category
Vaccines research, development and implementation
Research Subcategory
Vaccine design and administration
Special Interest Tags
Innovation
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
IosBio has developed a technology which enables the generation of thermally stable, orally administered vaccines. We will utilise this technology to develop a candidate Nipah vaccine, a disease identified as having pandemic potential.